AH-7921 (Doxylam) is an opioid analgesic drug selective for the μ-opioid receptor, having around 90% the potency of morphine when administered orally. [2] [3] [4] It was discovered in the …

AH-7921 is a structurally unique synthetic opioid analgesic that has recently entered the drug arena in Europe, the USA, and Japan. Although it was synthesized and patented in the mid …

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) is a new synthetic opioid and has led to multiple non-fatal and fatal intoxications. To comprehensively study AH …

The AH-7921, a benzamide compound belonging to the U-compounds, developed by Allen and Hanburys Ltd. in the mid-1970s, has been very active in this group. Before the postulation of …

AH 7921 (Item No. 12036) is an analytical reference material categorized as an opioid. 1 It is an analgesic with high addictive liability in animal models. 2,3 AH 7921 is regulated as a …

AH-7921 is a central nervous system depressant. In addition to analgesia, relaxation, euphoria, so-called opiate glow, and alertness, occasional itching, nausea and tremors have been …

Oct 10, 2014 · Since 2012, a new synthetic opioid named AH-7921 has become available within the recreational drug market 1. AH-7921, IUPAC name 3,4-dichloro-N-[[1 …

It establishes a mechanism for the rapid exchange of information on new psychoactive substances and provides for an assessment of the risks associated with them in order to …

AH-7921 is a structurally unique synthetic opioid analgesic that has recently entered the drug arena in Europe, the USA, and Japan. Although it was synthesized and patented in the mid …

AH-7921 is a new, structurally atypical synthetic opioid analgesic that appears to be sold as a ‘‘research chemical’’ or ‘‘legal opioid’’ on the Internet since 2012.